Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung. [electronic resource]
Producer: 20060213Description: 8774-85 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carboplatin -- administration & dosage
- Carcinoma, Large Cell -- drug therapy
- Carcinoma, Neuroendocrine -- drug therapy
- Carcinoma, Small Cell -- drug therapy
- Cisplatin -- administration & dosage
- DNA Mutational Analysis
- Deoxycytidine -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Immunohistochemistry
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Multivariate Analysis
- Neoplasm Staging
- Paclitaxel -- administration & dosage
- Polymerase Chain Reaction
- Proto-Oncogene Proteins c-kit -- biosynthesis
- Proto-Oncogene Proteins c-met -- biosynthesis
- Receptor Protein-Tyrosine Kinases -- biosynthesis
- Receptor, Platelet-Derived Growth Factor alpha -- biosynthesis
- Receptor, Platelet-Derived Growth Factor beta -- biosynthesis
- Survival Analysis
- Survival Rate
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.